HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Tamaki Selected Research

SA 3443

11/2005Suppression of laser-induced choroidal neovascularization by oral administration of SA3443 in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Tamaki Research Topics

Disease

83Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
62Neoplasms (Cancer)
12/2021 - 01/2002
17Choroidal Neovascularization
10/2012 - 11/2002
12Neoplasm Metastasis (Metastasis)
12/2021 - 06/2002
11Lymphatic Metastasis
05/2019 - 05/2002
11Macular Degeneration (Age-Related Maculopathy)
03/2010 - 12/2005
4Stroke (Strokes)
10/2011 - 02/2009
3Neoplasm Micrometastasis
01/2016 - 11/2003
2Carcinoma (Carcinomatosis)
10/2021 - 01/2005
2Brain Neoplasms (Brain Tumor)
09/2021 - 11/2013
2Disease Progression
05/2021 - 01/2009
2Hypertension (High Blood Pressure)
11/2017 - 12/2009
2Neutropenia
01/2017 - 04/2012
2Hypoxia (Hypoxemia)
06/2012 - 11/2005
2Pathologic Complete Response
08/2011 - 01/2009
2Polypoidal Choroidal Vasculopathy
03/2010 - 07/2006
2Cataract (Cataracts)
12/2009 - 07/2004
2Glaucoma
12/2009 - 11/2008
2Diabetes Mellitus
12/2009 - 07/2004
2Retinal Degeneration
08/2007 - 03/2007
2Obesity
03/2006 - 11/2003

Drug/Important Bio-Agent (IBA)

27Estrogen ReceptorsIBA
01/2018 - 01/2002
26Messenger RNA (mRNA)IBA
10/2021 - 01/2002
14Epirubicin (Ellence)FDA LinkGeneric
07/2012 - 03/2003
11Progesterone Receptors (Progesterone Receptor)IBA
11/2013 - 01/2002
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2012 - 01/2003
9Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 01/2009
8Nucleic AcidsIBA
05/2019 - 08/2007
8Proteins (Proteins, Gene)FDA Link
01/2016 - 06/2002
8Estrogens (Estrogen)FDA Link
06/2012 - 05/2003
8Docetaxel (Taxotere)FDA Link
11/2008 - 01/2002
7DNA (Deoxyribonucleic Acid)IBA
02/2012 - 06/2008
7EnzymesIBA
03/2006 - 05/2003
6Hormones (Hormone)IBA
08/2014 - 03/2004
6TamoxifenFDA LinkGeneric
03/2009 - 01/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012 - 11/2002
5Fluorouracil (Carac)FDA LinkGeneric
05/2012 - 11/2005
5Retinaldehyde (Retinal)IBA
03/2010 - 09/2006
5Aromatase (CYP19)IBA
11/2006 - 06/2003
5Codon (Codons)IBA
07/2004 - 09/2002
4human ERBB2 proteinIBA
09/2021 - 01/2009
4Hematoxylin (Haematoxylon)IBA
01/2016 - 01/2002
4Eosine Yellowish-(YS) (Eosin)IBA
01/2016 - 01/2002
4MicellesIBA
04/2009 - 01/2004
3Biomarkers (Surrogate Marker)IBA
01/2016 - 12/2005
3Aromatase InhibitorsIBA
08/2014 - 01/2003
3ErbB Receptors (EGF Receptor)IBA
11/2013 - 06/2009
3AnthracyclinesIBA
04/2010 - 03/2003
3Anastrozole (Arimidex)FDA LinkGeneric
06/2009 - 01/2003
3TubulinIBA
03/2009 - 09/2002
31-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2008 - 12/2005
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2006 - 12/2004
3Interleukin-6 (Interleukin 6)IBA
11/2006 - 12/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2006 - 12/2004
3Estradiol (Delestrogen)FDA LinkGeneric
12/2004 - 05/2003
2Biological ProductsIBA
09/2021 - 01/2007
2Phenobarbital (Luminal)FDA Link
09/2021 - 05/2012
2RNA (Ribonucleic Acid)IBA
05/2021 - 06/2007
2Bevacizumab (Avastin)FDA Link
01/2017 - 09/2007
2Ranibizumab (Lucentis)FDA Link
09/2010 - 02/2009
2Coloring Agents (Dyes)IBA
04/2010 - 03/2003
2Retinal Pigments (Pigments, Visual)IBA
12/2009 - 05/2008
2Keratin-19 (Keratin 19)IBA
04/2009 - 08/2007
2Photosensitizing Agents (Photosensitizers)IBA
04/2009 - 12/2005
2Peptides (Polypeptides)IBA
03/2009 - 05/2008
2CalciumIBA
01/2009 - 11/2008
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2008 - 08/2006
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2008 - 03/2008
2RacivirIBA
04/2008 - 01/2005
2Verteporfin (Visudyne)FDA Link
03/2008 - 07/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2008 - 08/2006
2AdiponectinIBA
06/2007 - 11/2003
2InterleukinsIBA
11/2006 - 04/2006
2SulfatasesIBA
11/2006 - 06/2003
2Steryl-Sulfatase (Steroid Sulfatase)IBA
11/2006 - 06/2003
23 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
11/2006 - 06/2003
2Pharmaceutical PreparationsIBA
08/2006 - 11/2002
2ImmunosorbentsIBA
03/2006 - 11/2005
2Cytochrome P-450 CYP3AIBA
01/2005 - 01/2002
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2003 - 06/2002
1MyogeninIBA
12/2021
1DesminIBA
12/2021
1Coenzyme A (CoA)IBA
10/2021

Therapy/Procedure

16Therapeutics
01/2017 - 01/2002
15Neoadjuvant Therapy
01/2016 - 06/2004
14Segmental Mastectomy (Lumpectomy)
01/2022 - 01/2002
12Drug Therapy (Chemotherapy)
12/2021 - 01/2002
5Mastectomy (Mammectomy)
05/2008 - 01/2003
4Radiotherapy
01/2017 - 11/2013
4Lasers (Laser)
10/2012 - 11/2005
4Adjuvant Chemotherapy
08/2011 - 01/2002
4Photochemotherapy (Photodynamic Therapy)
04/2009 - 12/2005
3Lymph Node Excision (Lymph Node Dissection)
11/2021 - 10/2014
3Oral Administration
11/2008 - 11/2005
2Light Coagulation
12/2009 - 01/2009
2Vitrectomy
04/2009 - 09/2006
2Immunotherapy
05/2008 - 03/2004
2Transplantation
08/2007 - 03/2007
2Mammaplasty (Breast Reconstruction)
01/2007 - 11/2002
1Myocutaneous Flap
01/2022